| Symbol | ISPC |
|---|---|
| Name | ISPECIMEN INC. |
| Sector | HEALTH CARE |
| Region | North America |
| Industry | Biotechnology: Commercial Physical & Biological Resarch |
| Address | 450 BEDFORD STREET, LEXINGTON, Massachusetts, 02420, United States |
| Telephone | +1 781 301-6700 |
| Fax | — |
| — | |
| Website | https://www.ispecimen.com |
| Incorporation | UNDEFINED |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | — |
| Public Since | — |
| Exchanges | NASDAQ |
| Auditor | — |
| Audit Status | NOT PROVIDED |
| Reporting Status | — |
| CIK | 0001558569 |
| Description | iSpecimen Inc is a technology-driven company focused on connecting life science researchers who need human biofluids, tissues, and living cells for their research, with the available biospecimens. Its iSpecimen Marketplace platform solves this problem and transforms the biospecimen procurement process to accelerate medical discovery. Geographically, it has a presence in the Americas; Europe, Middle East, and Africa, and Asia Pacific. Additional info from NASDAQ: |
iSpecimen Inc. Announces Closing of $5 Million Public Offering of Common Stock and Pre-Funded Warrants
Read moreiSpecimen Inc. Announces Closing of $5 Million Public Offering of Common Stock and Pre-Funded Warrants
Read moreNew Form 424B4 - iSpecimen Inc. <b>Filed:</b> 2026-08-07 <b>AccNo:</b> 0001213900-26-086434 <b>Size:</b> 784 KB
Read moreiSpecimen Inc. Announces Pricing of $5 Million Public Offering of Common Stock and Pre-Funded Warrants
Read moreiSpecimen Inc. Announces Pricing of $5 Million Public Offering of Common Stock and Pre-Funded Warrants
Read moreNew Form S-1/A - iSpecimen Inc. <b>Filed:</b> 2026-07-06 <b>AccNo:</b> 0001213900-26-075593 <b>Size:</b> 1 MB
Read moreNew Form S-1 - iSpecimen Inc. <b>Filed:</b> 2026-06-24 <b>AccNo:</b> 0001213900-26-071550 <b>Size:</b> 1 MB
Read moreNew Form EFFECT - iSpecimen Inc. <b>Filed:</b> 2026-06-17 <b>AccNo:</b> 9999999995-26-002047 <b>Size:</b> 1 KB
Read more| Trial ID | Title | Phase | Indication | Status | Start Date | Completion Date | Source |
|---|---|---|---|---|---|---|---|
| NCT03884400 | Distribution of Biospecimens From Biorepositories/Biobanks for Research Use | — | Cancer | Withdrawn | 2021-01-01 | 2026-03-01 | ClinicalTrials.gov |
| NCT05080907 | Collection and Distribution of Biospecimens for Novel Research | — | Cancer | Unknown | 2016-07-15 | 2025-01-01 | ClinicalTrials.gov |
| NCT03848962 | Collection and Distribution of Biospecimens for Novel Research Uses | — | Cancer | Recruiting | 2016-06-30 | 2026-12-31 | ClinicalTrials.gov |
| Product Name | Type | Development Stage | Therapeutic Area | Study Status | Trial ID |
|---|---|---|---|---|---|
| Observational | Other | Preclinical | Cancer | UNKNOWN | NCT05080907 |
| Specimens obtained from surgical, phlebotomy or other non-invasive procedure | Procedure | Preclinical | Cancer | WITHDRAWN | NCT03884400 |
| Observational | OTHER | Preclinical | Cancer | UNKNOWN | NCT05080907 |
| Specimens obtained from surgical, phlebotomy or other non-invasive procedure | PROCEDURE | Preclinical | Cancer | WITHDRAWN | NCT03884400 |